Racial and Ethnic Disparities in Participation at Alzheimer's Disease Research Centers

Carol Chan,Kathleen A. Lane,Sujuan Gao,Omolola A. Adeoye-Olatunde,Basil Alhassan,Shannon L. Risacher,Andrew J. Saykin,Sophia Wang

DOI: https://doi.org/10.1016/j.jagp.2024.01.178

2024-04-01

Abstract:Introduction Two million older Americans from underrepresented racial and ethnic minority groups (URGs) have early-stage Alzheimer's disease and related dementias (ADRD). Recent neuroimaging and clinical trials focus on individuals with early-stage ADRD, which is crucial to the development of disease modification strategies. Despite recognition of the need to increase URG engagement in these studies, enrollment remains low. A major barrier to improving URG participation rates is the lack of best practices in recruitment and referral processes. The aim of these analyses was to take a first step in examining reasons for these disparities by comparing referral sources for ADRC enrollment of URG participants with early-stage ADRD. Methods These analyses included data from 48,330 participants across 46 ADRCs, obtained through the National Alzheimer's Coordinating Center Uniform Data Set. Descriptive statistics from 5 racial/ethnic groups at baseline (visit 1) were compared using one-way analysis of variance models (ANOVAs) and chi-square tests. Generalized multinomial logistic regression models were used to examine the association of racial/ethnic group and the types of referral sources (professional, non-professional and other), with ‘non-professional’ as the reference category. The ‘professional’ category included referrals made by healthcare professionals or ADRC staff, while the ‘non-professional’ category included referrals made by family and friends. This association was examined in three samples: (1) the entire sample, (2) individuals with a baseline diagnosis of mild cognitive impairment (MCI) or dementia and a baseline global Clinical Depression Rating (CDR) of 0.5 or 1, and (3) individuals who had completed magnetic resonance imaging (MRI) at any point and a baseline diagnosis of MCI or dementia and a baseline global CDR of 0.5 or 1. Significance was set at p <0.05. Results Descriptive statistics are shown in Table 1. The sample included 35,358 (73.2%) Non-Hispanic White participants, 4,138 (8.6%) Hispanic participants, 6,766 (14%) Non-Hispanic Black participants, 1,392 (2.9%) Non-Hispanic Asian participants, and 676 (1.4%) participants of other racial and ethnic groups. Across the entire sample, Non-Hispanic Black participants were less likely to be referred by a professional contact than Non-Hispanic White participants, but more likely to be referred by family or friends (Table 2). A similar pattern was observed in participants who had a diagnosis of MCI or dementia and a global CDR of 0.5 or 1 at baseline - both overall (Table 3) and in those who had completed MRI (Table 4). These findings remained significant after adjusting for age, gender, education, and CDR score. Conclusions A lack of healthcare professional-facilitated recruitment may contribute to the disproportionately lower research participation in URGs in early-stage ADRD, including those who are willing to complete investigations such as MRI. There is a need at a national level to develop recruitment strategies to increase URG representation, particularly for Non-Hispanic Black older adults. Further studies are needed to examine how factors affecting health equity may contribute to this disparity.

psychiatry,geriatrics & gerontology,gerontology